Targeted dual inhibition of c‐Met/VEGFR2 signalling by foretinib improves antitumour effects of nanoparticle paclitaxel in gastric cancer models

Journal of Cellular and Molecular Medicine

Changhua Zhang¹  Margaret A. Schwarz²  Meghan Grojean³  Johann R. Schwarz³  Niranjan Awasthi⁴  Sazzad Hassan⁴  Urz von Holzen⁵  Roderich E. Schwarz⁶ 

[1] Department of Gastrointestinal Surgery, The Seventh Affiliated Hospital of Sun Yat‐sen University, Shenzhen, China;Department of Pediatrics, Indiana University School of Medicine, South Bend, IN, USA;Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA;Department of Surgery, Indiana University School of Medicine, South Bend, IN, USA;Department of Surgery, Indiana University School of Medicine, South Bend, IN, USA;Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA;Department of Surgery, Indiana University School of Medicine, South Bend, IN, USA;Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA;Goshen Center for Cancer Care, Goshen, IN, USA;University of Basel, Basel, Switzerland;Department of Surgery, Indiana University School of Medicine, South Bend, IN, USA;Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA;Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA;University of Buffalo, Buffalo, NY, USA;

关键词: c‐Met;    combination therapy;    foretinib;    gastric cancer;    nab;   

DOI  :  10.1111/jcmm.16362

来源: Wiley

【 授权许可】

CC BY